This inventor holds 1 USPTO granted patent. Top assignee: University of Michigan. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Yingjiang Zhou - Innovator in Metabolic Disorder Treatments
Introduction
Yingjiang Zhou is a notable inventor based in Arlington, MA (US). He has made significant contributions to the field of medicine, particularly in the treatment of metabolic disorders and cardiovascular diseases. His innovative approach focuses on the use of lipocalins, which are proteins that play a crucial role in various biological processes.
Latest Patents
Yingjiang Zhou holds a patent titled "Methods of administering lipocalins to treat metabolic disorders and cardiovascular diseases." This patent describes a method of treating an LCN13-related condition by administering a therapeutically effective amount of a lipocalin or a physiologically active fragment thereof to a patient in need. This innovative method has the potential to improve treatment options for patients suffering from these conditions. He has 1 patent to his name.
Career Highlights
Zhou is affiliated with the University of Michigan, where he continues to advance research in his field. His work has garnered attention for its potential impact on healthcare and treatment methodologies. His dedication to innovation in medical science is evident through his research and patent contributions.
Collaborations
Yingjiang Zhou collaborates with Liangyou Rui, a fellow researcher, to further explore the applications of lipocalins in medical treatments. Their partnership exemplifies the collaborative spirit of scientific research, aiming to enhance the understanding and treatment of metabolic disorders.
Conclusion
Yingjiang Zhou's work in the field of metabolic disorders showcases the importance of innovation in medicine. His patented methods offer promising avenues for treatment, reflecting his commitment to improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
